Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

274
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
274
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

557
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
557
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

256
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
256
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

748
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
748
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

249
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK, High-Throughput PBPK, and Machine Learning.

Molecular pharmaceutics·2026
Same author

PQRI Workshop: Model-Informed Drug Development (MIDD) Approaches in Pediatric Formulation Development.

The AAPS journal·2026
Same author

Novel selective morpholine trace amine-associated receptor 1 partial agonists show promising preclinical effects for neuropsychiatric disorders and are well tolerated in healthy volunteers.

Molecular psychiatry·2026
Same author

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges.

CPT: pharmacometrics & systems pharmacology·2025
Same author

The "five-star matrix" for patient-centric drug discovery and development in neuroscience.

Neuron·2025
Same author

Optimization of In Vitro CYP3A4 TDI Assay Conditions and Use of Derived Parameters for Clinical DDI Risk Assessment Using Static and Dynamic Models.

The AAPS journal·2025

Related Experiment Video

Updated: Feb 1, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

High-Throughput Physiologically Based Pharmacokinetic Model for Rodent Pharmacokinetics Prediction Using Machine

Davide Bassani1, Andrea Andrews-Morger1, Jin Zhang1

  • 1Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.

Molecular Pharmaceutics
|January 30, 2026
PubMed
Summary

High-throughput physiologically based pharmacokinetic (HT-PBPK) modeling accurately predicts drug properties using only chemical structures. This accelerates drug discovery by replacing extensive in vitro testing with reliable in silico predictions.

Keywords:
PK predictioncompound optimizationdrug discoveryhigh-throughput PBPK (HT-PBPK)machine learning (ML)

More Related Videos

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.4K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

735

Related Experiment Videos

Last Updated: Feb 1, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.4K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

735

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Computational Chemistry and Cheminformatics
  • Drug Discovery and Development

Background:

  • Accurate pharmacokinetic (PK) prediction is vital for efficient drug discovery, but traditional methods like physiologically based pharmacokinetic (PBPK) models are limited by low throughput and data requirements.
  • High-throughput PBPK (HT-PBPK) methods enable rapid, large-scale simulations, while machine learning (ML) allows PK prediction directly from chemical structures, bypassing the need for in vitro data.

Purpose of the Study:

  • To evaluate the performance of a corporate HT-PBPK application (SwiftPK) for predicting ten PK endpoints in a large dataset of rodent PK data.
  • To assess the feasibility of replacing in vitro data with in silico predictions generated by an ML pipeline for early-stage drug discovery.

Main Methods:

  • The SwiftPK application, utilizing an HTPK simulation module, was applied to over 9000 compounds.
  • An ML pipeline was used to generate in silico predictions for all in vitro parameter inputs, replacing experimental data.
  • Performance was evaluated against rodent PK data, with specific analysis for compounds cleared by hepatic metabolism and high-confidence ML predictions.

Main Results:

  • The HT-PBPK approach demonstrated highly predictive performance, with most PK endpoints predicted within a three- to four-fold error.
  • Prediction accuracy improved for compounds predicted to be cleared by hepatic metabolism (Extended Clearance Classification System class 2) and when using high-confidence ML inputs.
  • Key factors for successful early-phase application include accurate prediction of the primary elimination pathway and high prediction quality.

Conclusions:

  • The study validates the utility of HT-PBPK with in silico ML-derived inputs for accelerating early-stage drug discovery.
  • This approach is particularly valuable for lead identification and collaborations lacking experimental data.
  • Adoption of HT-PBPK can expedite the development of novel therapeutics by improving the efficiency and reliability of PK predictions.